STAA (Staar Surgical Co) 3-Year RORE % : 47.44% (As of Mar. 2026)


STAA Staar Surgical Co STAA
83 GF Score
Price $27.78
GF Value $31.64
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co 3-Year RORE %?

Staar Surgical Co STAA -1.31% 83 3-Year RORE % is 47.44 as of Mar. 2026. GuruFocus rates STAA with a GF Score™ of 83/100 and a GF Value™ of $31.64 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 782 Medical Devices & Instruments companies, Staar Surgical Co ranks better than 85.04% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Staar Surgical Co's 3-Year RORE % for the quarter that ended in Mar. 2026 was 47.44%.

The industry rank for Staar Surgical Co's 3-Year RORE % or its related term are showing as below:

STAA's 3-Year RORE % is ranked better than
85.04% of 782 companies
in the Medical Devices & Instruments industry
Industry Median: -4.31 vs STAA: 47.44

Staar Surgical Co  (NAS:STAA) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Staar Surgical Co 3-Year RORE % Related Terms


Staar Surgical Co 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co 3-Year RORE % Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.95 47.80 -3.53 -148.75 127.95

Staar Surgical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 424.49 222.94 208.93 127.95 47.44

STAA vs BLFS, ATRC, KMTS: 3-Year RORE % Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's 3-Year RORE % falls into.


STAA
83GF Score
Staar Surgical Co STAA
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co 3-Year RORE % Calculation

Staar Surgical Co's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.43-0.31 )/( -1.56-0 )
=-0.74/-1.56
=47.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 47.44 mean?
Staar Surgical Co (STAA) has a 3-Year RORE % of 47.44 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Staar Surgical Co and its competitors. According to the industry distribution chart, Staar Surgical Co ranks #117 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 15%.
Is Staar Surgical Co's 3-Year RORE % too high?
Staar Surgical Co's current 3-Year RORE % is 47.44. Based on the distribution chart, Staar Surgical Co ranks #117 out of 782 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Staar Surgical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's 3-Year RORE % compare to BLFS and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #117 out of 782 companies for 3-Year RORE %. This places Staar Surgical Co in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current 3-Year RORE % is 47.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.64, compared to a current price of $27.78 — trading 12.2% below its estimated fair value. The current 3-Year RORE % is 47.44. Staar Surgical Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current 3-Year RORE % is 47.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staar Surgical Co (STAA) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of $27.78 is trading 12.2% below its estimated GF Value™ of $31.64. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for STAA:

  • 3-Year RORE %: 47.44
  • GF Value™: $31.64 vs. price of $27.78 (12.2% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staar Surgical Co Business Description

Other Exchanges SR3:Germany
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score

Get the complete analysis for STAA

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.78
Price
$31.64
GF Value